{"entity":{"type":"insider","cik":"0001352413","url":"/insider/0001352413","json_url":"/insider/0001352413.json","name":"Capone Mark Christopher","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":42,"n_filings":17,"first":"2007-08-09","last":"2026-03-10","span_basis":"filed_date"},"name_variants":[{"name":"Capone Mark Christopher","source":"filing","n_filings":17,"first_seen":"2007-08-09","last_seen":"2026-03-10"}],"transactions":[{"id":5914350,"accession":"0000724004-26-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000724004-26-000022","line_url":"/filing/0000724004-26-000022#line-1","is_derivative":false,"issuer_cik":"0000724004","issuer_name":"MESA LABORATORIES INC /CO/","issuer_ticker":"MLAB","issuer_name_source":null,"issuer_url":"/issuer/0000724004","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1301.0,"shares_display":"1,301","price_per_share":76.35,"price_display":"76.35","price_state":"stated","total_value":99331.35,"total_display":"99,331.35","total_whole":"99,331","shares_owned_after":3429.0,"shares_owned_after_display":"3,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-10","filed_date":"2026-03-10","scope":"insider"},{"id":7894753,"accession":"0001352413-19-000002","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001352413-19-000002","line_url":"/filing/0001352413-19-000002","is_derivative":false,"issuer_cik":"0000899923","issuer_name":"MYRIAD GENETICS INC","issuer_ticker":"MYGN","issuer_name_source":null,"issuer_url":"/issuer/0000899923","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Officer (President & C.E.O)","role_mark":"O","role_mark_label":"Officer (President & C.E.O)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & C.E.O.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":137000.0,"shares_display":"137,000","price_per_share":44.0,"price_display":"44.00","price_state":"stated","total_value":6028000.0,"total_display":"6,028,000.00","total_whole":"6,028,000","shares_owned_after":440833.0,"shares_owned_after_display":"440,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-01","filed_date":"2019-08-02","scope":"insider","n_lines":4},{"id":6054138,"accession":"0001352413-18-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001352413-18-000004","line_url":"/filing/0001352413-18-000004","is_derivative":false,"issuer_cik":"0000899923","issuer_name":"MYRIAD GENETICS INC","issuer_ticker":"MYGN","issuer_name_source":null,"issuer_url":"/issuer/0000899923","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Officer (President & C.E.O)","role_mark":"O","role_mark_label":"Officer (President & C.E.O)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & C.E.O.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":41.0,"price_display":"41.00","price_state":"stated","total_value":3280000.0,"total_display":"3,280,000.00","total_whole":"3,280,000","shares_owned_after":332175.0,"shares_owned_after_display":"332,175","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-11","filed_date":"2018-07-13","scope":"insider","n_lines":2},{"id":6537723,"accession":"0000899243-18-014717","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-014717","line_url":"/filing/0000899243-18-014717#line-2","is_derivative":false,"issuer_cik":"0000899923","issuer_name":"MYRIAD GENETICS INC","issuer_ticker":"MYGN","issuer_name_source":null,"issuer_url":"/issuer/0000899923","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Officer (President & C.E.O)","role_mark":"O","role_mark_label":"Officer (President & C.E.O)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & C.E.O.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90000.0,"shares_display":"90,000","price_per_share":38.0,"price_display":"38.00","price_state":"stated","total_value":3420000.0,"total_display":"3,420,000.00","total_whole":"3,420,000","shares_owned_after":332175.0,"shares_owned_after_display":"332,175","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-06-01","scope":"insider"},{"id":3145369,"accession":"0001352413-16-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001352413-16-000006","line_url":"/filing/0001352413-16-000006#line-1","is_derivative":false,"issuer_cik":"0000899923","issuer_name":"MYRIAD GENETICS INC","issuer_ticker":"MYGN","issuer_name_source":null,"issuer_url":"/issuer/0000899923","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Officer (President & C.E.O)","role_mark":"O","role_mark_label":"Officer (President & C.E.O)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & C.E.O.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":21.24,"price_display":"21.24","price_state":"stated","total_value":212400.0,"total_display":"212,400.00","total_whole":"212,400","shares_owned_after":146026.0,"shares_owned_after_display":"146,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-19","filed_date":"2016-08-19","scope":"insider"},{"id":6976262,"accession":"0001352413-14-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001352413-14-000004","line_url":"/filing/0001352413-14-000004","is_derivative":false,"issuer_cik":"0000899923","issuer_name":"MYRIAD GENETICS INC","issuer_ticker":"MYGN","issuer_name_source":null,"issuer_url":"/issuer/0000899923","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Officer (President, MGL)","role_mark":"O","role_mark_label":"Officer (President, MGL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, MGL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95250.0,"shares_display":"95,250","price_per_share":37.83,"price_display":"37.83","price_state":"stated","total_value":3603307.5,"total_display":"3,603,307.50","total_whole":"3,603,308","shares_owned_after":48268.0,"shares_owned_after_display":"48,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-25","filed_date":"2014-02-25","scope":"insider","n_lines":2},{"id":6587893,"accession":"0001352413-14-000002","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001352413-14-000002","line_url":"/filing/0001352413-14-000002","is_derivative":false,"issuer_cik":"0000899923","issuer_name":"MYRIAD GENETICS INC","issuer_ticker":"MYGN","issuer_name_source":null,"issuer_url":"/issuer/0000899923","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Officer (President, MGL)","role_mark":"O","role_mark_label":"Officer (President, MGL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, MGL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87500.0,"shares_display":"87,500","price_per_share":32.0676,"price_display":"32.07","price_state":"stated","total_value":2805915.0,"total_display":"2,805,915.00","total_whole":"2,805,915","shares_owned_after":48268.0,"shares_owned_after_display":"48,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-10","filed_date":"2014-02-10","scope":"insider","n_lines":2},{"id":4891823,"accession":"0001352413-13-000002","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001352413-13-000002","line_url":"/filing/0001352413-13-000002","is_derivative":false,"issuer_cik":"0000899923","issuer_name":"MYRIAD GENETICS INC","issuer_ticker":"MYGN","issuer_name_source":null,"issuer_url":"/issuer/0000899923","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Officer (President, MGL)","role_mark":"O","role_mark_label":"Officer (President, MGL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, MGL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79999.0,"shares_display":"79,999","price_per_share":33.2318,"price_display":"33.23","price_state":"stated","total_value":2658510.7682,"total_display":"2,658,510.77","total_whole":"2,658,511","shares_owned_after":48268.0,"shares_owned_after_display":"48,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-16","filed_date":"2013-05-17","scope":"insider","n_lines":2},{"id":2354969,"accession":"0001352413-12-000014","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001352413-12-000014","line_url":"/filing/0001352413-12-000014#line-6","is_derivative":false,"issuer_cik":"0000899923","issuer_name":"MYRIAD GENETICS INC","issuer_ticker":"MYGN","issuer_name_source":null,"issuer_url":"/issuer/0000899923","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Officer (President, MGL)","role_mark":"O","role_mark_label":"Officer (President, MGL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, MGL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":314.0,"shares_display":"314","price_per_share":30.034,"price_display":"30.03","price_state":"stated","total_value":9430.676,"total_display":"9,430.68","total_whole":"9,431","shares_owned_after":48268.0,"shares_owned_after_display":"48,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-21","filed_date":"2012-11-21","scope":"insider"},{"id":2354961,"accession":"0001352413-12-000014","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001352413-12-000014","line_url":"/filing/0001352413-12-000014","is_derivative":false,"issuer_cik":"0000899923","issuer_name":"MYRIAD GENETICS INC","issuer_ticker":"MYGN","issuer_name_source":null,"issuer_url":"/issuer/0000899923","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Officer (President, MGL)","role_mark":"O","role_mark_label":"Officer (President, MGL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, MGL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35010.0,"shares_display":"35,010","price_per_share":30.41,"price_display":"30.41","price_state":"stated","total_value":1064654.1,"total_display":"1,064,654.10","total_whole":"1,064,654","shares_owned_after":48268.0,"shares_owned_after_display":"48,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-20","filed_date":"2012-11-21","scope":"insider","n_lines":2},{"id":2174541,"accession":"0001352413-12-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001352413-12-000012","line_url":"/filing/0001352413-12-000012#line-2","is_derivative":false,"issuer_cik":"0000899923","issuer_name":"MYRIAD GENETICS INC","issuer_ticker":"MYGN","issuer_name_source":null,"issuer_url":"/issuer/0000899923","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Officer (President, MGL)","role_mark":"O","role_mark_label":"Officer (President, MGL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, MGL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62176.0,"shares_display":"62,176","price_per_share":29.9118,"price_display":"29.91","price_state":"stated","total_value":1859796.0768,"total_display":"1,859,796.08","total_whole":"1,859,796","shares_owned_after":48268.0,"shares_owned_after_display":"48,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-12","filed_date":"2012-11-13","scope":"insider"},{"id":3312855,"accession":"0001352413-12-000010","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001352413-12-000010","line_url":"/filing/0001352413-12-000010","is_derivative":false,"issuer_cik":"0000899923","issuer_name":"MYRIAD GENETICS INC","issuer_ticker":"MYGN","issuer_name_source":null,"issuer_url":"/issuer/0000899923","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Officer (President, MGL)","role_mark":"O","role_mark_label":"Officer (President, MGL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, MGL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":28.75,"price_display":"28.75","price_state":"stated","total_value":776250.0,"total_display":"776,250.00","total_whole":"776,250","shares_owned_after":48268.0,"shares_owned_after_display":"48,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-06","filed_date":"2012-11-08","scope":"insider","n_lines":2},{"id":2866909,"accession":"0001352413-12-000006","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001352413-12-000006","line_url":"/filing/0001352413-12-000006","is_derivative":false,"issuer_cik":"0000899923","issuer_name":"MYRIAD GENETICS INC","issuer_ticker":"MYGN","issuer_name_source":null,"issuer_url":"/issuer/0000899923","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Officer (President, MGL)","role_mark":"O","role_mark_label":"Officer (President, MGL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, MGL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19805.0,"shares_display":"19,805","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":534735.0,"total_display":"534,735.00","total_whole":"534,735","shares_owned_after":49268.0,"shares_owned_after_display":"49,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-10","filed_date":"2012-09-12","scope":"insider","n_lines":3},{"id":3312837,"accession":"0001352413-12-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001352413-12-000004","line_url":"/filing/0001352413-12-000004","is_derivative":false,"issuer_cik":"0000899923","issuer_name":"MYRIAD GENETICS INC","issuer_ticker":"MYGN","issuer_name_source":null,"issuer_url":"/issuer/0000899923","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Officer (President, MGL)","role_mark":"O","role_mark_label":"Officer (President, MGL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, MGL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4257.0,"shares_display":"4,257","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":114939.0,"total_display":"114,939.00","total_whole":"114,939","shares_owned_after":49268.0,"shares_owned_after_display":"49,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-02","filed_date":"2012-05-04","scope":"insider","n_lines":2},{"id":5712850,"accession":"0001352413-09-000008","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001352413-09-000008","line_url":"/filing/0001352413-09-000008","is_derivative":false,"issuer_cik":"0000899923","issuer_name":"MYRIAD GENETICS INC","issuer_ticker":"MYGN","issuer_name_source":null,"issuer_url":"/issuer/0000899923","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Officer (Chief Operating Officer, MGL)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer, MGL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer, MGL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36000.0,"shares_display":"36,000","price_per_share":43.06875,"price_display":"43.07","price_state":"stated","total_value":1550475.0,"total_display":"1,550,475.00","total_whole":"1,550,475","shares_owned_after":20454.0,"shares_owned_after_display":"20,454","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-04-06","filed_date":"2009-04-07","scope":"insider","n_lines":2},{"id":5661840,"accession":"0001352413-09-000002","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001352413-09-000002","line_url":"/filing/0001352413-09-000002","is_derivative":false,"issuer_cik":"0000899923","issuer_name":"MYRIAD GENETICS INC","issuer_ticker":"MYGN","issuer_name_source":null,"issuer_url":"/issuer/0000899923","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Officer (Chief Operating Officer, MGL)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer, MGL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer, MGL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21893.0,"shares_display":"21,893","price_per_share":85.3989,"price_display":"85.40","price_state":"stated","total_value":1869638.1177,"total_display":"1,869,638.12","total_whole":"1,869,638","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-09","filed_date":"2009-02-11","scope":"insider","n_lines":3},{"id":3719299,"accession":"0001352413-08-000004","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001352413-08-000004","line_url":"/filing/0001352413-08-000004","is_derivative":false,"issuer_cik":"0000899923","issuer_name":"MYRIAD GENETICS INC","issuer_ticker":"MYGN","issuer_name_source":null,"issuer_url":"/issuer/0000899923","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Officer (Chief Operating Officer, MGL)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer, MGL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer, MGL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":67.934,"price_display":"67.93","price_state":"stated","total_value":1222812.0,"total_display":"1,222,812.00","total_whole":"1,222,812","shares_owned_after":6081.0,"shares_owned_after_display":"6,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-29","filed_date":"2008-09-03","scope":"insider","n_lines":5},{"id":8160957,"accession":"0001352413-07-000006","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001352413-07-000006","line_url":"/filing/0001352413-07-000006","is_derivative":false,"issuer_cik":"0000899923","issuer_name":"MYRIAD GENETICS INC","issuer_ticker":"MYGN","issuer_name_source":null,"issuer_url":"/issuer/0000899923","owner_cik":"0001352413","owner_name":"Capone Mark Christopher","owner_display_name":"Capone Mark Christopher","owner_url":"/insider/0001352413","role":"Officer (Chief Operating Officer, MGL)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer, MGL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer, MGL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4773.0,"shares_display":"4,773","price_per_share":43.006075843285146,"price_display":"43.01","price_state":"stated","total_value":205268.0,"total_display":"205,268.00","total_whole":"205,268","shares_owned_after":6081.0,"shares_owned_after_display":"6,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-07","filed_date":"2007-08-09","scope":"insider","n_lines":6}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":42,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":40,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":42},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000724004","name":"MESA LABORATORIES INC /CO/","url":"/issuer/0000724004","role":"Director","n_filings":1,"first_seen":"2026-03-10","last_seen":"2026-03-10"},{"type":"issuer","type_label":"ISSUER","cik":"0000899923","name":"MYRIAD GENETICS INC","url":"/issuer/0000899923","role":"Officer (President & C.E.O)","n_filings":16,"first_seen":"2007-08-09","last_seen":"2019-08-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001352413","retrieved_at":"2026-08-27T02:38:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}